XML 22 R13.htm IDEA: XBRL DOCUMENT
v3.23.3

STOCKHOLDERS' EQUITY | 3 Months Ended
--- | ---
Sep. 30, 2023
STOCKHOLDERS' EQUITY |
STOCKHOLDERS' EQUITY | NOTE 7 — STOCKHOLDERS’ EQUITY In 2019, the Company adopted the 2019 Omnibus Incentive Plan (the “Plan”). The Plan, as amended, provides for the issuance of stock-based awards to employees. As of September 30, 2023, the Plan provides for the issuance of up to 1,500,000 stock-based awards. There are 1,220,000 stock-based awards available to grant under the Plan at September 30, 2023. In July 2021, MiT Inc. entered into an Exchange Agreement with MiT LLC pursuant to which MiT Inc. agreed to exchange membership units for 2,350,000 shares of Common Stock representing 41.4% of the equity as of such date on a fully diluted basis for no consideration. The shares were exchanged as part of the Exchange Agreement with the Company as described in Note 1. In July 2021, the Company granted options to non-employee directors to purchase an aggregate of 150,000 shares of its common stock at an exercise price of $3.00 per share. The options vest one year from the date of grant, expire ten years from the date of grant and had an aggregate grant date fair value of $244,200, which will be recognized ratably over the vesting period. On May 26, 2023, the Board of Directors cancelled 150,000 options consisting of 50,000 options each to John Stiska, Katherine Crothall and Scott Anderson with an exercise price of $3.00. In its place, the Board granted 150,000 options consisting of 50,000 options each with an exercise price of $1.10 vesting immediately to John Stiska, Katherine Crothall and Scott Anderson. In addition to the director options, the Board granted CFO William Greene 100,000 options with an exercise price of $1.10 with 25% vesting immediately the remainder vesting at 25% per year thereafter. These options, which were the only options granted during the year ended June 30, 2023, had a grant-date fair value of $1.10 per share. The Company recognized compensation expense for stock option awards of approximately $113,000 during the year ended June 30, 2023. None of these potentially dilutive securities were included in the computation of diluted earnings per share as their impact would be anti-dilutive. The Company recognized $5,000 in compensation expense for stock options during the three months ended September 30, 2023. On March 6, 2023, the Board of Directors (the “Board”) of Moving iMage Technologies, Inc. (the “Company”) approved an amendment (the “Amendment”) to the Company’s Amended and Restated Bylaws that amends the quorum for a stockholders’ meeting or action to be at least 33 1/3% of all shares of stock issued and outstanding and entitled to vote thereat, present in person or represented by proxy. At September 30, 2023, there was no unrecognized compensation cost related to nonvested stock option awards and no option grants during the period. The estimated fair value of each option award granted was determined on the date of grant using the Black-Scholes option valuation model. No options were granted during the three months ended September 30, 2023. The following weighted average assumptions were used for option grants during the three months ended June 30, 2023: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Director | ​ | ​ | Officer | ​
​ | ​ | Options | ​ | ​ | Options | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
Risk-free interest rate |  | 3.92 | % | ​ | 3.86 | %
Expected volatility |  | 82.0 | % | ​ | 82.0 | %
Dividend yield |  | — | % | ​ | — | %
Expected option term in years |  | 5 |  | ​ | 7 |
​ ​ On March 23, 2023 the Board of Directors re-authorized a stock repurchase program. Under the stock repurchase program, the Company may repurchase up to $1 million of its outstanding common stock over the next 12 months. During the period of March 24 through June 30, 2023, the Company repurchased 272,620 of the Company’s stock representing 2.55% of the 10,685,778 outstanding NOTE 7 — STOCKHOLDERS’ EQUITY (continued) shares at the end of June 30, 2023 at an average price of $1.11 per share. There were no share repurchases for the three months ended September 30, 2023. ​ $ in Thousands, except shares and dollar per share amounts ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  |  |  | ​ |  |  | Total Number of |  | Approximate
​ | ​ | ​ | ​ | ​ | ​ | ​ | Shares | ​ | Dollar Value of
​ | ​ | ​ | ​ | ​ | ​ | ​ | Purchased as | ​ | Shares that May
​ | ​ | Total Number of | ​ | ​ | ​ | ​ | Part of Publicly | ​ | Yet Be Purchased
​ | ​ | Shares | ​ | Average Price | ​ | Announced Plans | ​ | Under the Plans
Period | ​ | Purchased | ​ | Paid per Share | ​ | or Programs | ​ | or Programs
March 23, 2023 – June 30, 2023 | ​ | 272,620 | ​ | $ | 1.11 | ​ | 272,620 | ​ | $ | 697,000
Total | ​ | 272,620 | ​ | $ | 1.11 | ​ | 272,620 | ​ | $ | 697,000
​ On July 12, 2022, the Company granted 130,000 shares of common stock, with a fair market value of approximately $153,000, to employees as compensation for previously provided service, which was accrued as of June 30, 2022. ​ A summary of the status of the Company’s stock options as of September 30, 2023 and changes during the three months ended September 30, 2023 are presented below. ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Wtd. Avg.
​ | ​ | ​ | ​ | Exercise
​ | ​ | Options | ​ | Price
Balance, July 1, 2023 |  | 250,000 | ​ | $ | 1.10
Granted during the year |  | — | ​ |  | —
Exercised during the year |  | — | ​ |  | —
Cancelled during the year |  | — | ​ |  | —
Balance, September 30, 2023 |  | 250,000 | ​ | $ | 1.10
​ A summary of the status of the Company’s stock options as of September 30, 2022 and changes during the three months ended September 30, 2022 are presented below. ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Wtd. Avg.
​ | ​ | ​ | ​ | Exercise
​ | ​ | Options | ​ | Price
Balance, July 1, 2022 |  | — | ​ | $ | —
Granted during the period |  | 150,000 | ​ |  | 3.00
Exercised during the period |  | — | ​ |  | —
Terminated/Expired during the period |  | — | ​ |  | —
Balance, September 30, 2022 |  | 150,000 | ​ | $ | 3.00
​ The following table summarizes information about outstanding and exercisable stock options at September 30, 2023: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Range of |  | Number |  | Number |  | ​ |  | Wtd. Avg.
Exercise Price | ​ | Outstanding | ​ | Exercisable | ​ | Wtd. Avg, Life | ​ | Exercise Price
$1.10 |  | 250,000 |  | 175,000 |  | 9.0 years | ​ | $1.10
​ There was no warrant activity during the year ended June 30, 2023 or for the three months ended September 30, 2023.

X
- Definition n/a + References No definition available. + Details
Name: | mitq_StockholdersMembersEquityAndStockBasedCompensationAbstract
Namespace Prefix: | mitq_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for information about stockholders equity and stock based compensation. + References No definition available. + Details
Name: | mitq_StockholdersMembersEquityAndStockBasedCompensationTextBlock
Namespace Prefix: | mitq_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration